Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.
MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.
The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.
A germ-fighting robot that uses pulsed xenon ultraviolet (UV) light to sanitize rooms at Trinity Hospital is giving a boost to the hospital's infection control program.
Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.
After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph).
An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world's most dangerous superbugs.
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.
The introduction of methicillin into clinical practice is not what caused the emergence of methicillin resistant Staphylococcus aureus (MRSA), report researchers. According to a collaborative study by the University of St Andrews, University of Dundee and the Wellcome Trust Sanger Institute, MRSA existed long before clinicians started using the antibiotic.
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains.
CANCER researchers in the UK may have stumbled across a solution to reverse antibiotic drug resistance and stop infections like MRSA.
Even if hospital workers practice perfect hand hygiene, MRSA can still spread among babies in the NICU, according to new research led by a Drexel University researcher.
Foster Corporation, a leader in polymer solutions for healthcare markets, introduces Combat™ antimicrobial master batches for blending with medical device polymers.
Children with bloodstream infections caused by methicillin-resistant Staphylococcus aureus, a common antibiotic-resistant bacteria, are less likely to die than adults with this condition and have different risk factors for treatment failure, a new study led by a Children's National Health System clinician indicates.
Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.
Hospital room floors may be an overlooked source of infection, according to a study published in the March issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.
A new antibiotic, produced by bacteria found on a species of African ant, is very potent against antibiotic-resistant 'superbugs' like MRSA according to scientists.
A new tool -- a type of ultraviolet light called UVC -- could aid hospitals in the ongoing battle to keep drug-resistant bacteria from lingering in patient rooms and causing new infections.
A first-of-its-kind study of 900,000 hospital admissions from an integrated health system has yielded insights into shifts in the epidemiology of multi-drug resistant organisms (MDROs) in the community.
The Perelman School of Medicine at the University of Pennsylvania has been awarded more than $1 million by the U.S. Centers for Disease Control and Prevention (CDC) to develop new approaches to combat antibiotic resistance.
Ultraviolet C light disinfection to clean unoccupied patient rooms significantly reduced C. difficile infections (CDI) in high-risk patients who later occupied those rooms, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
A new study offers compelling evidence that a novel form of the dangerous superbug Methicillin-Resistant Staphylococcus aureus (MRSA) can spread to humans through consumption or handling of contaminated poultry.